Trial	Type: efficacy or safety	Follow‐up time
RV1 Anh 2011‐PHL	Safety	1 month after last dose
RV1 Anh 2011‐VNM	Safety	1 month after last dose
RV1 Bernstein 1998‐USA	Safety	1 month
RV1 Bernstein 1999‐USA	Efficacy/Safety	2 years
RV1 Colgate 2016‐BGD	Efficacy	1 year
RV1 Dennehy 2005‐NA	Safety	10 to 12 months
RV1 GSK[021] 2007‐PAN	Safety	1 month after dose 3
RV1 GSK[033] 2007‐LA	Safety	1 month
RV1 GSK[041] 2007‐KOR	Safety	2 months
RV1 GSK[101555] 2008‐PHL	Safety	1 month
RV1 Kawamura 2011‐JPN	Efficacy/Safety	Up to the age of 2 years
RV1 Kerdpanich 2010‐THA	Safety	2 months after last dose
RV1 Kim 2012‐KOR	Safety	1 month after last dose
RV1 Li 2013a‐CHN	Safety	1 month
RV1 Li 2013b‐CHN	Safety	1 month
RV1 Li 2014‐CHN	Efficacy/Safety	2 years
RV1 Madhi 2010‐AF	Efficacy/Safety	2 years
RV1 Narang 2009‐IND	Safety	1 month
RV1 NCT00158756‐RUS	Safety	1 year
RV1 Omenaca 2012‐EU	Safety	At least 1 month after dose 2
RV1 Phua 2005‐SGP	Efficacy/Safety	Until infant aged 18 months (ie 13 to 15 months)
RV1 Phua 2009‐AS	Efficacy/Safety	3 years
RV1 Rivera 2011‐DOM	Safety	17 weeks after each dose
RV1 Ruiz‐Palac 06‐LA/EU	Efficacy/Safety	9 to 10 months
RV1 Salinas 2005‐LA	Efficacy/Safety	Up to 2 years
RV1 Steele 2008‐ZAF	Safety	Up to 6 months
RV1 Steele 2010a‐ZAF	Safety	31 days after each dose, 42 days after the last dose
RV1 Steele 2010b‐ZAF	Safety	Up to 6 months
RV1 Tregnaghi 2011‐LA	Efficacy/Safety	Up to age 1 year
RV1 Vesikari 2004a‐FIN	Safety	8 to 30 days after each dose
RV1 Vesikari 2004b‐FIN	Efficacy/Safety	1 and 2 years (both reported)
RV1 Vesikari 2007a‐EU	Efficacy/Safety	1 and 2 years (plus 3 years in Finland)
RV1 Vesikari 2011‐FIN	Safety	2 months
RV1 Ward 2006‐USA	Safety	7 days after each vaccination; 3 to 5 weeks after dose 2
RV1 Zaman 2009‐BGD	Safety	31 days
RV1 Zaman 2017‐BGD	Effectiveness	2 years
RV5 Armah 2010‐AF	Efficacy/Safety	Up to 43 days for safety outcomes, up to 21 months for efficacy outcomes
RV5 Block 2007‐EU/USA	Efficacy/Safety	42 days for safety/immunogenicity; 1 year for efficacy
RV5 Ciarlet 2009‐EU	Safety	42 days
RV5 Clark 2003‐USA	Efficacy/Safety	1 year
RV5 Clark 2004‐USA	Efficacy/Safety	1 year
RV5 Dhingra 2014‐IND	Safety	1 month
RV5 Iwata 2013‐JPN	Efficacy/Safety	25 months
RV5 Kim 2008‐KOR	Safety	42 days
RV5 Lawrence 2012‐CHN	Safety	2 weeks after last dose
RV5 Levin 2017‐AF	Safety	1 month
RV5 Merck[009] 2005‐USA	Safety	42 days
RV5 Mo 2017‐CHN	Efficacy/Safety	2 years
RV5 Vesikari 2006a‐FIN	Efficacy/Safety	1 to 3 years
RV5 Vesikari 2006b‐INT	Efficacy/Safety	43 days for safety; 2 years for efficacy
RV5 Zaman 2010‐AS	Efficacy/Safety	Up to 43 days for safety outcomes, up to 2 years for efficacy outcomes
VAC Bhandari 2006‐IND	Safety	1 month
VAC Bhandari 2009‐IND	Safety	12 weeks
VAC Bhandari 2014‐IND	Efficacy/Safety	up to 2 years of age
VAC Chandola 2017‐IND	Safety	1 year